Inventor · disambiguated record
Elisabete Goncalves
Also filed as: GONCALVES ELISABETE
4 granted patents·8 pending applications·6 citations·filing 2008–2024
68Inventor score
Top patents by PatentIndex Score
12 records- 0183US10596178B2Tablet formulation of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl) imidazo [1,2-B] [1,2,4] triazin-2-yl] benzamideNOVARTIS AG·Filed 2018·Granted Mar 24, 2020·4 cites·1 claims
- 0283US2025339440A1Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamideNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0376US10085993B2Tablet formulation of 2-fluoro-N-methyl-4-[ 7-( quinolin-6-ylmethyl) imidazo [1,2-B] [1,2,4] triazin-2-yl] benzamideNOVARTIS AG·Filed 2015·Granted Oct 2, 2018·2 cites·1 claims
- 0475US12208101B2Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamideNOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·9 claims
- 0564US2021113569A1Tablet Formulation of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Ylmethyl) Imidazo [1,2-B] [1,2,4] Triazin-2-YL] BenzamideNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0658US2010178336A1Stabilized amorphous forms of imatinib mesylateNOVARTIS AG·Filed 2008·Application pending·0 cites
- 0752US2013022672A1Stabilized Amorphous Forms of Imatinib MesylateNOVARTIS AG·Filed 2012·Application pending·0 cites
- 0849US2014323495A1Stabilized Amorphous Forms of Imatinib MesylateGONCALVES ELISABETE·Filed 2014·Application pending·0 cites
- 0946US2013225598A1Stabilized Amorphous Forms of Imatinib MesylateGONCALVES ELISABETE·Filed 2013·Application pending·0 cites
- 1044US2010022565A1Pharmaceutical compositionsBUHL THOMAS·Filed 2008·Application pending·0 cites
- 1133US10188696B2Pharmaceutical compositionsGONCALVES ELISABETE·Filed 2016·Granted Jan 29, 2019·0 cites·10 claims
- 1229US2014005123A1Pharmaceutical compositionsGONCALVES ELISABETE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elisabete Goncalves files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →